After medical training is complete and you transition into full-time patient care, research often falls by the wayside. But taking part in clinical studies while maintaining your practice can be immensely advantageous. It keeps you on the cutting edge of your specialty by exposing you to the latest tools and treatment options, allows you to further expand your career into publishing and speaking—both of...
After medical training is complete and you transition into full-time patient care,...
One of the best ways to get your practice in front of your most likely prospective...
For close to a decade, R. Rox Anderson, MD, PhD, and Fernanda Sakamoto, MD, of the...
Dermatologist and former Marine flight surgeon Jorge Garcia-Zuazaga, MD, credits his...
Cynosure TempSure Surgical radiofrequency (RF) technology—a new addition to...
Skinceuticals Glycolic 10 Renew Overnight is a corrective night cream that...
Radiance Shield Anti-Aging Lotion from Skinprint protects skin to reduce...
Canfield Scientific’s VECTRA H2 offers an all-in-one portable lightweight 3D...
 A novel dual-wavelength, dual-pulse duration laser was evaluated for use on solar lentigines in 20 Asian patients with results showing 90 percent of patients achieved moderate to significant improvement. The study device was a dual‐wavelength, dual‐pulse width Nd:YAG laser that allowed for...
|
Almirall has joined the American Acne and Rosacea Society (AARS) as a sponsor to help highlight the global health burden of acne during National Acne Awareness Month in June.
The mission of the AARS is to promote, support, develop and provide an educational forum for the exchange of information...
|
A novel dual-wavelength, dual-pulse duration laser was evaluated for use on solar lentigines in 20 Asian patients with results showing 90 percent of patients achieved moderate to significant improvement. The study device was a dual‐wavelength, dual‐pulse width Nd:YAG laser that allowed for treatment with a 532nm or 1,064 nm wavelength in a 750 picosecond pulse duration. The treating physicians used the 532nm wavelength as its effect would be confined more superficially, which is ideal for the treatment of lengitines, and because it has greater melanin absorption than 1,064nm. Furthermore, the 532nm wavelength posed less risk of adverse pigmentation events in darker skin types.
A total of 89 lesions in 20 patients were treated with the laser setting of 532nm, 750 picosecond pulse duration, fluence of 0.2–0.5 J/cm2, and spot size of 4 mm with a repetition rate of 2 Hz. The fluence was selected to achieve clinical endpoint, which was slight whitening immediately after laser shot at targeted pigment lesion. Fifty‐three of 89 (59.6 percent) lesions cleared with one laser session. Twenty‐four lesions required two treatments and 12 lesions required three treatments. Treatments were spaced 4 to 6 weeks apart.
...Almirall has joined the American Acne and Rosacea Society (AARS) as a sponsor to help highlight the global health burden of acne during National Acne Awareness Month in June.
The mission of the AARS is to promote, support, develop and provide an educational forum for the exchange of information, to promote clinical research and mentoring opportunities for dermatology healthcare professionals, and to improve the care of patients who suffer from acne and rosacea. The goal of National Acne Awareness Month is to drive interest and knowledge among the next generation of dermatology healthcare providers to better serve these patients.
“As part of our partnership with AARS, Almirall is advancing education and dialogue by being one of the sponsors of this organization,” said Sam Widdicombe, executive director at Almirall U.S. “We are proud of our ongoing assistance and support for the dermatology community, and we believe that these efforts will help stimulate interest and ultimately result in effectively managing acne among emerging specialists so they can better help patients.”
“The global health burden of acne ranks just below that of all dermatosis combined, and above that of psoriasis, which is talked about...
Connecticut has adopted legislation that allows students, with permission from a parent or guardian, to self-apply sunscreen during the school day. Senate bill 922 is based on SUNucate model legislation, developed by the American Society for Dermatologic Surgery Association (ASDSA). It allows students six years or older to possess and self-apply over-the-counter sunscreen in school before outdoor activities, if a parent or guardian has provided written authorization to the school nurse. Connecticut is the 23rd state—and sixth state this year—to enact such legislation.
“The momentum of the passage of SUNucate legislation throughout the U.S. demonstrates lawmakers’ commitment in these states to promoting sun-safe behavior in children,” said ASDSA President Murad Alam, MD, MBA. “I congratulate Connecticut for adopting this important bill, and hope other states without similar legislation will consider following Connecticut’s lead.”
The Sunucate model legislation is a key part of the SUNucate initiative developed to address barriers to sunscreen use in school and camps and promote sun-safe behavior. ASDSA worked with the 60-member SUNucate Coalition, which includes state and national medical specialties and patient...
The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.
The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.
The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »
Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.
Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »
